{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:02:24Z","timestamp":1785286944148,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["90578"],"award-info":[{"award-number":["90578"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["76734"],"award-info":[{"award-number":["76734"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T17:35:57Z","timestamp":1587144957000},"page":"4006-4015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats"],"prefix":"10.1016","volume":"38","author":[{"given":"D.D.","family":"Lazarus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Peta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Blight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Van Heerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B.","family":"Mutowembwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Blignaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Opperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.T.","family":"Fosgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.014_b0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2020.04.014_b0010","first-page":"1","article-title":"Cellular response to persistent foot-and-mouth disease virus infection is linked to specific types of alterations in the host cell transcriptome","volume":"8","author":"Han","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.04.014_b0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S0950268810000580","article-title":"Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field","volume":"139","author":"Sangula","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.04.014_b0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-1702(02)00263-0","article-title":"Foot and mouth disease in wildlife","volume":"91","author":"Thomson","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.04.014_b0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fmicb.2016.00528","article-title":"Transmission of foot-and-mouth disease SAT2 viruses at the wildlife-livestock interface of two major transfrontier conservation areas in Southern Africa","volume":"7","author":"Brito","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.21775\/9781910190517.09","article-title":"Natural habitats in which foot-and-mouth disease viruses are maintained","author":"Vosloo","year":"2017","journal-title":"Foot Mouth Disease Virus Current Res Emerg Trends"},{"key":"10.1016\/j.vaccine.2020.04.014_b0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1865-1682.2011.01204.x","article-title":"The pathogenesis of foot-and-mouth disease I: viral pathways in cattle","volume":"58","author":"Arzt","year":"2011","journal-title":"Transboundary Emerg Dis"},{"key":"10.1016\/j.vaccine.2020.04.014_b0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1865-1682.2011.01236.x","article-title":"The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions","volume":"58","author":"Arzt","year":"2011","journal-title":"Transboundary Emerg Dis"},{"key":"10.1016\/j.vaccine.2020.04.014_b0045","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1016\/j.vaccine.2018.08.073","article-title":"Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine","volume":"36","author":"Horsington","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0050","first-page":"505","article-title":"Clinical variation in foot and mouth disease: sheep and goats","volume":"21","author":"Kitching","year":"2002","journal-title":"Revue Scientifique et Technique (International Office of Epizootics)"},{"key":"10.1016\/j.vaccine.2020.04.014_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.smallrumres.2019.09.014","article-title":"Clinical presentation of FMD virus SAT1 infections in experimentally challenged indigenous South African goats","volume":"180","author":"Lazarus","year":"2019","journal-title":"Small Ruminant Res"},{"key":"10.1016\/j.vaccine.2020.04.014_b0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nature01343","article-title":"Modelling vaccination strategies against foot-and-mouth disease","volume":"421","author":"Keeling","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.014_b0065","unstructured":"FAO. Foot and mouth disease vaccination monitoring Guidelines. FAO, Rome; 2016."},{"key":"10.1016\/j.vaccine.2020.04.014_b0070","unstructured":"OIE World Organisation for Animal Health. Foot and Mouth disease (FMD). Animal Health in the World 2018. (accessed April 23, 2019). http:\/\/www.oie.int\/en\/animal-health-in-the-world\/animal-diseases\/Foot-and-mouth-disease\/."},{"key":"10.1016\/j.vaccine.2020.04.014_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.04.014_b0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4102\/ojvr.v75i1.84","article-title":"Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes","volume":"75","author":"Cloete","year":"2008","journal-title":"Onderstepoort J Veterinary Res"},{"key":"10.1016\/j.vaccine.2020.04.014_b0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7774\/cevr.2013.2.1.8","article-title":"Requirements for improved vaccines against foot-and-mouth disease epidemics","volume":"2","author":"Park","year":"2013","journal-title":"Clin Experim Vaccine Res"},{"key":"10.1016\/j.vaccine.2020.04.014_b0090","first-page":"883","article-title":"Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines","volume":"15","author":"Doel","year":"1996","journal-title":"Revue Scientifique et Technique (International Office of Epizootics)"},{"key":"10.1016\/j.vaccine.2020.04.014_b0095","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.vaccine.2015.04.058","article-title":"Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge","volume":"33","author":"Maree","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0100","first-page":"913","article-title":"The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines","volume":"15","author":"Hunter","year":"1996","journal-title":"Revue Scientifique et Technique (International Office of Epizootics)"},{"key":"10.1016\/j.vaccine.2020.04.014_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0264-410X(97)00170-9","article-title":"Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa","volume":"16","author":"Hunter","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-1157(82)80046-2","article-title":"Sources of variations encountered during the selection and production of three strains of FMD virus for the development of vaccine for use in Nigeria","author":"Preston","year":"1982","journal-title":"J Biolog Standardizat"},{"key":"10.1016\/j.vaccine.2020.04.014_b0115","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1016\/j.vaccine.2017.02.003","article-title":"Evaluation of immune responses of stabilised SAT2 antigens of foot-and-mouth disease in cattle","volume":"35","author":"Scott","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0120","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.vaccine.2018.02.096","article-title":"A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species","volume":"36","author":"Mouton","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0125","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.rvsc.2011.10.006","article-title":"Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa foot-and-mouth disease monovalent vaccine and challenge in goats and comparison with sheep","volume":"93","author":"Madhanmohan","year":"2012","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2020.04.014_b0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12088-011-0101-x","article-title":"Immune response in goats to different payloads of FMDV monovalent vaccine: protection against virulent challenge and development of carrier status","volume":"51","author":"Madhanmohan","year":"2011","journal-title":"Indian J Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11259-010-9353-x","article-title":"Protection against direct in-contact challenge following foot-and-mouth disease vaccination in sheep and goats: the effect on virus excretion and carrier status","volume":"34","author":"Madhanmohan","year":"2010","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2020.04.014_b0140","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2014.07.040","article-title":"Enhanced immune responses of foot-and-mouth disease vaccine using new oil\/gel adjuvant mixtures in pigs and goats","volume":"32","author":"Park","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1865-1682.2008.01056.x","article-title":"Immune response in goats to two commercial foot-and-mouth disease vaccines and the assessment of maternal immunity in their kids","volume":"56","author":"Madhanmohan","year":"2009","journal-title":"Transboundary Emerg Dis"},{"key":"10.1016\/j.vaccine.2020.04.014_b0150","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1128\/JCM.40.11.4367-4371.2002","article-title":"Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: Rate of development of immunity and variations among other ruminants","volume":"40","author":"Patil","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.prevetmed.2018.08.003","article-title":"Serological responses of cattle inoculated with inactivated trivalent foot-and-mouth disease vaccine at the wildlife-livestock interface of the Kruger National Park South Africa","volume":"158","author":"Lazarus","year":"2018","journal-title":"Prevent Veterinary Med"},{"key":"10.1016\/j.vaccine.2020.04.014_b0160","first-page":"172","article-title":"Randomised controlled trials (RCTS) - Sample size: The magic number?","volume":"44","author":"Chan","year":"2003","journal-title":"Singapore Med J"},{"key":"10.1016\/j.vaccine.2020.04.014_b0165","article-title":"Effect of FMD vaccine antigen payload on protection, sub-clinical infection and persistence following needle challenge in sheep","author":"Madhanmohan","year":"201033","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.014_b0170","article-title":"A simple method of estimating 50 percent end-points. American","author":"Reed","year":"1938","journal-title":"J Hygiene"},{"key":"10.1016\/j.vaccine.2020.04.014_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/am.22.1.1-5.1971","article-title":"Growth of the IB-RS-2 pig kidney cell line in suspension culture and its susceptibility to foot-and-mouth disease virus","volume":"22","author":"Chapman","year":"1971","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0180","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1016\/j.vaccine.2019.07.002","article-title":"A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus","volume":"37","author":"Sirdar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jcpa.2004.05.002","article-title":"Determinants of early foot-and-mouth disease virus dynamics in pigs","volume":"131","author":"Quan","year":"2004","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jviromet.2003.09.016","article-title":"Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE)","volume":"115","author":"Paiba","year":"2004","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2020.04.014_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0166-0934(01)00333-0","article-title":"A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus","volume":"97","author":"Mackay","year":"2001","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2020.04.014_b0200","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s007050050390","article-title":"Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus","volume":"143","author":"Sorensen","year":"1998","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0205","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2460\/javma.2002.220.1636","article-title":"Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus","volume":"220","author":"Callahan","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2020.04.014_b0210","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1099\/vir.0.18859-0","article-title":"The implications of virus diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa","volume":"84","author":"Bastos","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0215","doi-asserted-by":"crossref","DOI":"10.1111\/tbed.13493","article-title":"Characterization of SAT2 foot-and-mouth disease 2013\/2014 outbreak viruses at the wildlife\u2013livestock interface in South Africa","author":"Blignaut","year":"2020","journal-title":"Transboundary Emerg Dis"},{"key":"10.1016\/j.vaccine.2020.04.014_b0220","article-title":"BIOEDIT: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/ NT","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp Ser"},{"key":"10.1016\/j.vaccine.2020.04.014_b0225","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2020.04.014_b0230","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0","author":"Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2020.04.014_b0235","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0264-410X(01)00503-5","article-title":"A review of emergency foot-and-mouth disease (FMD) vaccines","volume":"20","author":"Barnett","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0240","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0264-410X(98)00486-1","article-title":"Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission","volume":"17","author":"Cox","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2018.02.006","article-title":"Development and validation of a foot-and-mouth disease virus SAT serotype-specific 3ABC assay to differentiate infected from vaccinated animals","author":"Chitray","year":"2018","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2020.04.014_b0250","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.vaccine.2003.11.003","article-title":"Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus","volume":"22","author":"Ebl\u00e9","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0255","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.vaccine.2015.04.045","article-title":"Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination","volume":"33","author":"Vosloo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.014_b0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.20506\/rst.21.3.1343","article-title":"Clinical variation in foot and mouth disease: cattle","volume":"21","author":"Kitching","year":"2002","journal-title":"Revue Scientifique et Technique International Office of Epizootics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:15:54Z","timestamp":1777536954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":52,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304849"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}